Impact Factor
3.01
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.19
275 total citations
h5-index
22
h5 depth signal
Cited share
61.5%
83 of 135
Total citations
275
Citation footprint
Metric signal
1.85
External metric anchor
Self-citation
9.1%
25 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United Kingdom
424
United States
166
Australia
81
Canada
43
Sweden
33
Citing Fields of Research
Reproductive Health
612
Human Reproduction
81
Obstetrics/Gynecology
80
Sexually Transmitted Diseases
54
HIV
41
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,957
Articles tracked across the journal lifetime
Indexed publication set
135
83 cited publications
Last 12 months
76
6.9 publications/month
Open access share
43.4%
33 OA publications in the last year
Leading citing country
United Kingdom
424 citing publications
Leading citing field
Reproductive Health
612 citing publications
Latest tracked publication
14 October 2026
10 recent records available
Coverage & Indexing History
v44n1, Jan. 2018-
v44n1, Jan. 2018-
Research Focus & Classification
Indexed Subjects
Reproductive Health
Issuing & Sponsoring Bodies
issuing body
Royal College of Obstetricians and Gynaecologists (Great Britain). Faculty of Sexual & Reproductive Health Care
Broad Categories
Family Planning Services
Reproductive Medicine
Reproductive Health
MeSH Descriptors
Contraception
Reproductive Health
Reproductive Medicine
Sexual Health
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1136/bmjsrh-2025-203056
Open DOI
Highlights of literature
02
DOI 10.1136/bmjsrh-2026-203355
Open DOI
Adolescents’ experiences accessing emergency contraception in Australian community pharmacies: a qualitative study
03
DOI 10.1136/bmjsrh-2026-203281
Open DOI
Design and development of AbortionCareTXT, a text message programme for individuals undergoing medication abortion
Background: In Canada, medication abortion accounts for approximately 30% of the 100 000 annual abortions. Despite the advantages of privacy and autonomy, many individuals report feeling unprepared and uninformed about the medication abo...
04
DOI 10.1136/bmjsrh-2026-203239
Open DOI
Contraceptive and hormonal medication decision-making for pregnancy prevention and gynaecological symptoms: a systematic review and conceptual framework
Background: There has been a decline in the number of contraceptive appointments and prescriptions in the UK. Existing evidence explores the impact of access, barriers and awareness on contraception use. However, less is known about the ...
05
DOI 10.1136/bmjsrh-2026-203398
Open DOI
Sexual and reproductive health needs of young adults with chronic conditions in the USA and Canada: a scoping review
Introduction: Young adults with chronic conditions, including epilepsy, congenital heart disease (CHD) and systemic lupus erythematosus (SLE), face unique sexual and reproductive health (SRH) challenges. Limited access to age-appropriate...
06
07
DOI 10.1136/bmjsrh-2026-203332
Open DOI
Efficacy, safety and acceptability of the use of 68 mg etonogestrel contraceptive subdermal implant for up to 5 years compared with up to 3 years: a systematic review
Background: Prolonging the use of the etonogestrel (ENG) implant beyond the currently approved duration of 3 years could offer substantial benefits including improved accessibility, reduced need for replacements and overall lower healthc...
08
DOI 10.1136/bmjsrh-2026-203331
Open DOI
Effectiveness, safety and acceptability of continuous or extended-cycle use of combined oral contraceptives (COCs): a systematic review and meta-analysis
Background: To evaluate the contraceptive effectiveness, safety and acceptability of continuous or extended-cycle combined oral contraceptives (COCs) compared with conventional cyclic regimens (21/7 or 24/4). Methods: A systematic search...
09
DOI 10.1136/bmjsrh-2026-203330
Open DOI
Efficacy, safety and acceptability of once-monthly oral contraceptives containing quinestrol and quingestanol, quinestrol and levonorgestrel or quinestrol and norgestrel: a systematic review
Objective: To evaluate the efficacy, safety and acceptability of quinestrol combined with quingestanol (Quin-QUIN), quinestrol combined with levonorgestrel (Quin-LNG) and quinestrol combined with norgestrel (Quin-NG) as contraceptives. M...
10
DOI 10.1136/bmjsrh-2026-203329
Open DOI
Contraceptive effectiveness and safety of ormeloxifene: a systematic review
Objective: To systematically review the contraceptive safety and effectiveness of ormeloxifene, a non-hormonal selective oestrogen receptor modulator, among reproductive-age women. Methods: A comprehensive search was performed across MED...
Bibliographical & Catalog Notes
Also issued in print
"In partnership with FSRH the Faculty of Sexual & Reproductive Healthcare of the Royal College of Obstetricians & Gynaecologists."